Search

Author/Creator Tasanen, K.

7. Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study. (15th July 2022)

Authors:
Dikmen, H.O.; Yilmaz, K.; Benoit, S.; Bernard, P.; Drenovska, K.; Gerdes, S.; Gläser, R.; Günther, C.; Homey, B.; Horváth, O.N.; Huilaja, L.; Joly, P.; Kiritsi, D.; Meller, S.; Patsatsi, A.; Sárdy, M.; Schauer, F.; Shahid, M.; Sticherling, M.; Tasanen, K.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 36:Number 11(2022)
Page Start:
2181
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). (29th June 2022)

Authors:
Borradori, L.; Van Beek, N.; Feliciani, C.; Tedbirt, B.; Antiga, E.; Bergman, R.; Böckle, B. C.; Caproni, M.; Caux, F.; Chandran, N.S.; Cianchini, G.; Daneshpazhooh, M.; De, D.; Didona, D.; Di Zenzo, G. M.; Dmochowski, M.; Drenovska, K.; Ehrchen, J.; Goebeler, M.; Groves, R.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 36:Number 10(2022)
Page Start:
1689
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗